PRCN-408

N/A

Report date: 2025/01/26 16:46:37

Base Information

Drug NamePRCN-408
Drug Alias Namemacular degeneration gene therapy (Neuralgene)PRCN-408
ClassificationBiologics
Mechanisms of ActionComplement system proteins inhibitors
TargetsComplement system proteins
Therapy Area/IndicationsMacular Degeneration
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesNeuralgene
China Registration ClassN/A

Develop Information

Active CompaniesNeuralgene
Inactive CompaniesN/A
Active IndicationsMacular Degeneration
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A